arginine has been researched along with pravastatin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kakei, M; Nakata, M; Shiraishi, T; Yada, T | 1 |
| Arnesen, H; Eid, HM; Eritsland, J; Larsen, J; Seljeflot, I | 1 |
| Janatuinen, T; Knuuti, J; Laakso, J; Laaksonen, R; Lehtimäki, T; Nuutila, P; Raitakari, OT; Vesalainen, R | 1 |
| Deng, HF; Xiong, Y | 1 |
| Braunwald, E; DelMonte, T; Devlin, JJ; Dracopoli, NC; Hui, L; Iakoubova, OA; Kirchgessner, TG; Ranade, K; Sabatine, MS; Sacks, FM; Shaw, PM; Tsuchihashi, Z; Vishnupad, P; White, TJ | 1 |
| Carod-Artal, FJ | 1 |
| Averna, MR; Bucciarelli, L; Cefalù, AB; Ciabattoni, G; Davì, G; Davì, V; Ferrante, E; Noto, D; Pettinella, C; Santilli, F | 1 |
| Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M | 1 |
| Kiefte-de Jong, JC; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Guldener, C; van Ittersum, FJ | 1 |
| Li, J; Li, ZQ; Pan, W; Wang, LF | 1 |
| Fromm, MF; Glaeser, H; König, J; Mandery, K; Sticht, H | 1 |
| Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M | 1 |
| Ishibashi, Y; Matsui, T; Nakamura, K; Ohta, K; Okuda, S; Takeuchi, M; Tanoue, R; Ueda, S; Yamagishi, S | 1 |
| Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J | 1 |
| Alasztics, B; Csomó, KB; Czizel, R; Djurecz, M; Hrabák, A; Kecskeméti, A; Kovács, B; Kukor, Z; Pánczél, Z; Supák, D; Valent, S | 1 |
| Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E | 1 |
1 review(s) available for arginine and pravastatin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for arginine and pravastatin
| Article | Year |
|---|---|
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.
Topics: Arginine; Arteriosclerosis; Cholesterol, LDL; Diabetes Mellitus, Type 1; Female; Humans; Hypercholesterolemia; Incidence; Male; Pravastatin; Predictive Value of Tests; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity | 2003 |
Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults.
Topics: Adenosine; Adult; Anticholesteremic Agents; Arginine; Blood Flow Velocity; Coronary Circulation; Double-Blind Method; Enzyme Inhibitors; Humans; Hyperemia; Male; Nitric Oxide Synthase; Pravastatin; Regional Blood Flow; Tomography, Emission-Computed | 2003 |
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
Topics: Anticholesteremic Agents; Arginine; Atherosclerosis; Atorvastatin; Cross-Sectional Studies; Dinoprost; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Pravastatin; Pyrroles; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2007 |
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome | 2008 |
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Topics: Adult; Aged; Anticholesteremic Agents; Arginine; Carotid Arteries; Chronic Disease; Creatinine; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease.
Topics: Aged; Amino Acid Substitution; Arginine; Asian People; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Coronary Disease; Female; Gene Frequency; Genotype; Humans; Hypolipidemic Agents; Lipids; Lysine; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Pravastatin; Treatment Outcome | 2009 |
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Linear Models; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Quinolines; Stroke | 2011 |
10 other study(ies) available for arginine and pravastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells.
Topics: Animals; Arginine; Calcium; Calcium Channel Blockers; Calcium Channels; Cytosol; Glucose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Secretion; Islets of Langerhans; Potassium Chloride; Pravastatin; Rats; Signal Transduction; Simvastatin | 1999 |
Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta.
Topics: Alkaloids; Animals; Anticholesteremic Agents; Aorta, Thoracic; Arginine; Benzophenanthridines; Endothelium, Vascular; Free Radical Scavengers; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lysophosphatidylcholines; Male; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenanthridines; Pravastatin; Protein Kinase C; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2005 |
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.
Topics: Arginine; Aryldialkylphosphatase; Female; Gene Expression Regulation; Genetic Predisposition to Disease; Genotype; Glutamine; Heterozygote; Homozygote; Humans; Lipoproteins, LDL; Male; Multivariate Analysis; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Pravastatin; Risk; Risk Factors; Stroke | 2005 |
Statins and cerebral vasomotor reactivity: implications for a new therapy?
Topics: Adult; Animals; Arginine; Atorvastatin; Brain Ischemia; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Intracranial Aneurysm; Mice; Middle Cerebral Artery; Nitric Oxide; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Simvastatin; Stroke; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasomotor System; Vasospasm, Intracranial | 2006 |
Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3.
Topics: Alanine; Arginine; Biological Transport; Biological Transport, Active; Cell Membrane; Cellular Structures; Estrone; Glycine; Hepatocytes; Humans; Kinetics; Lysine; Organic Anion Transporters; Pharmaceutical Preparations; Pravastatin; Protein Structure, Secondary; Sulfobromophthalein | 2010 |
Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
Topics: Amidohydrolases; Apoptosis; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fluorobenzenes; Glycation End Products, Advanced; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules, Proximal; Pravastatin; Pyrimidines; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Up-Regulation | 2012 |
Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect.
Topics: Adult; Animals; Arginine; Blood Flow Velocity; Drug Combinations; Female; Fetal Growth Retardation; Gestational Age; Humans; In Vitro Techniques; Infant, Newborn; Infant, Premature; Live Birth; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Pilot Projects; Pravastatin; Pregnancy; Pregnancy, Twin; Premature Birth; Treatment Outcome; Twins, Dizygotic; Ultrasonography, Prenatal; Umbilical Arteries; Vascular Resistance; Vasodilation; Vasodilator Agents | 2018 |
Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas.
Topics: Adult; Arginine; Benzoquinones; Case-Control Studies; Citrulline; Enzyme Inhibitors; Female; Humans; Lactams, Macrocyclic; Microsomes; Nitric Oxide Synthase Type III; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy | 2019 |
Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
Topics: Adult; Arginine; Drug Therapy, Combination; Female; Fetal Growth Retardation; Hemodynamics; Humans; Live Birth; Pilot Projects; Placental Circulation; Placental Insufficiency; Pravastatin; Pre-Eclampsia; Pregnancy; Time Factors; Treatment Outcome; Ultrasonography, Doppler; Ultrasonography, Prenatal | 2021 |